PharmiWeb.com - Global Pharma News & Resources
11-Jul-2019

Hypertrophic and Keloid Scar Treatment Market Size Poised to Touch USD 10.5 Bn by 2026

The Global Hypertrophic and Keloid Scar Treatment Market Size to touch valuation around USD 10.5 billion by 2026, this market is anticipated to grow with 10% CAGR during the forecast time period 2018 to 2026. Rise in awareness about esthetic appeal has led to the market growth.

More than 40,000 hospitalizations resulted from burn injuries, the statistics as per American Burn Association, in 2016. This indicates an increase in the numberof burn injuries worldwide. These injuries cause visible hypertrophic scars, a common complication associated with them. Though, road accidents, leading to surgeries, can result in the growth of surgical marks.

Increase in burn injury cases has also led to augmented need for hypertrophic and keloid scar treatments. Plastic surgeries or resurfacing laser therapies are usually performed to eliminate these marks. Hypertrophic burn marks can affect a victimrsquo;s appearance and are related with other conditions, for instance, contractures and pruritis.

The global Hypertrophic and Keloid Scar Treatment Market is segmented into product, end-user, and region. On the basis of product, the global Hypertrophic and Keloid Scar Treatment Market is segmented into topical products, laser products, injectable, and others. The topical products sub-segment is further bifurcated into silicone sheets, creams, gels, and others. The laser product sub-segment is further bifurcated into pulse-dyed, co2 and others. On the basis of end-user, the global Hypertrophic and Keloid Scar Treatment Market is segmented into hospitals, clinics, and retail pharmacies/e-commerce. On the basis of scar type, the market is bifurcated into Hypertrophic and Keloid. On the basis of region, the global Hypertrophic and Keloid Scar Treatment Market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

On the basis of end user, hospitals sub-segment generated the maximum revenue in 2018 owing to the accessibility of an extensive range of cure options for scar removal. In case of emergencies, such as major accidents, hospitals are chosen for treatment as they deliver care during the recovery period as well.

Download Free Report Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/964

The clinics segment is anticipated to capture noteworthy market share in 2018 as they deliver specific treatment. In the greater part of the cases, patients visit hospitals for essential consideration and treatment and later follow up at strength centers. What's more, facilities frequently utilize mechanically propelled items. Every one of these elements are likewise added to the segment development. The retail pharmacies/e-commerce anticipated to show a noteworthy development over the forecast period as websites provide a wider variety of products.

Keloid segment held the largest market share in 2018 and is expected to record the fastest CAGR over the forecast timeframe. Unlike hypertrophic scars, surgical removal of keloid marks facilitates their regrowth. Therefore, they are treated with topical methods, for instance, silicone gel sheets and laser therapies. Cryotherapy, skin needling and pressure therapy are also some of the approaches used to decrease the size of the scar.

The hypertrophic sub-segment is expected to display a slow-moving growth over the forecast timeframe due to lower acceptance of treatments for the removal of these marks. The treatment usually involves non-invasive approaches, for instance, gels, silicone sheets, and creams, in case of slight injuries and laser therapies in case of adverse injuries. Though, in most cases, a mixture of two or more therapies is used for their treatment.

Market companies are concentrating on implementing new strategies, for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. And also, growing Ramp;D investments paired with technical advancements to commercialize highly efficient products are expected to offer huge growth opportunities for industry participants. Some of the main businesses present in the Hypertrophic and Keloid Scar Treatment Market are Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Smith amp; Nephew PLC, Mouml;lnlycke Health Care AB, Cynosure, Inc., and Enaltus, LLC. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.

Major producers have commenced strategic initiatives, for instance, product growth, mergers and acquisitions, and regional growth, to increase their business. Such as, in April 2017, Merz North America, Inc. declared the launch of Mederma Quick Dry Oil and Mederma Spezial for scar treatment.

View Complete Report at https://www.acumenresearchandconsulting.com/hypertrophic-and-keloid-scar-treatment-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Hypertrophic amp; Keloid Scar Treatment
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Hypertrophic amp; Keloid Scar Treatment Market By Scar Type
1.2.2.1. Global Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate Comparison By Scar Type (2015-2026)
1.2.2.2. Global Hypertrophic amp; Keloid Scar Treatment Market Revenue Share By Scar Type in 2017
1.2.2.3. Hypertrophic
1.2.2.4. Keloid
1.2.2.5. Others
1.2.3. Hypertrophic amp; Keloid Scar Treatment Market By Product
1.2.3.1. Global Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Topical Products
1.2.3.3. Laser products
1.2.3.4. Injectable
1.2.3.5. Others
1.2.4. Hypertrophic amp; Keloid Scar Treatment Market By End Users
1.2.4.1. Global Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Retail Pharmacies/E-commerce
1.2.4.5. Others
1.2.5. Hypertrophic amp; Keloid Scar Treatment Market by Geography
1.2.5.1. Global Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Hypertrophic amp; Keloid Scar Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Hypertrophic amp; Keloid Scar Treatment Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Hypertrophic amp; Keloid Scar Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Hypertrophic amp; Keloid Scar Treatment Major Manufacturers in 2017

CHAPTER 4. HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY SCAR TYPE

4.1. Global Hypertrophic amp; Keloid Scar Treatment Revenue By Scar Type
4.2. Hypertrophic
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Keloid
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY PRODUCT

5.1. Global Hypertrophic amp; Keloid Scar Treatment Revenue By Product
5.2. Topical Products
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Laser products
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Injectable
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY END USERS

6.1. Global Hypertrophic amp; Keloid Scar Treatment Revenue By End Users
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Retail Pharmacies/E-commerce
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

7.1. North America Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Hypertrophic amp; Keloid Scar Treatment Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

8.1. Europe Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

9.1. Asia-Pacific Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

10.1. Latin America Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

11.1. Middle East Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HYPERTROPHIC amp; KELOID SCAR TREATMENT MARKET BY COUNTRY

12.1. Africa Hypertrophic amp; Keloid Scar Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Hypertrophic amp; Keloid Scar Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Scar Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Sonoma Pharmaceuticals, Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Lumenis Ltd.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Suneva Medical, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Smith amp; Nephew PLC
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Mouml;lnlycke Health Care AB
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Cynosure, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Enaltus, LLC
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Others
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/964

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/964

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 11-Jul-2019